Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent miscarriage: pathophysiology and outcome.

Belinda Carrington1, Gavin Sacks, Lesley Regan

  • 1Department of Obstetrics and Gynaecology, Imperial College, St. Mary's Campus, London, UK. b.carrington@imperial.ac.uk

Current Opinion in Obstetrics & Gynecology
|November 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Women's and men's health strategies offer a shared agenda for reform.

BMJ (Clinical research ed.)·2026
Same author

Equity and Respect in Maternal and Infant Healthcare-A Report From the 2025 Venice Forum.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Why investing in women's health is a societal imperative.

Lancet (London, England)·2026
Same author

Ending the taboo on periods and period problems.

Nature medicine·2025
Same author

Abortion law reform in the UK.

BMJ (Clinical research ed.)·2025
Same author

Characterisation and comparison of semen microbiota and bacterial load in men with infertility, recurrent miscarriage, or proven fertility.

eLife·2025

Recurrent miscarriage treatments are evolving, with new data on genetic diagnosis, thrombophilias, and immune system roles. However, few therapies for unexplained recurrent miscarriage are rigorously tested beyond antiphospholipid syndrome treatments.

Area of Science:

  • Reproductive Medicine
  • Immunology
  • Genetics

Background:

  • Recurrent miscarriage (RM) affects couples with unexplained or known causes.
  • Understanding RM aetiology is crucial for effective treatment strategies.
  • Advances in genetics and immunology offer new insights into RM.

Purpose of the Study:

  • To review novel concepts in recurrent miscarriage aetiology.
  • To present updated outcome data for RM.
  • To evaluate emerging treatments for unexplained RM.

Main Methods:

  • Literature review of recent studies on RM.
  • Analysis of outcome data related to genetic testing and thrombophilias.
  • Evaluation of therapeutic interventions including thromboprophylaxis and insulin sensitizers.

Related Experiment Videos

Main Results:

  • Preimplantation genetic diagnosis is an option for RM.
  • Thromboprophylaxis shows promise for inherited thrombophilias.
  • Metformin may reduce miscarriage risk in insulin resistance.
  • Innate immune system activation is noted in successful pregnancies.

Conclusions:

  • Limited randomized controlled trials exist for most RM therapies.
  • Aspirin and heparin are proven for antiphospholipid syndrome.
  • Thromboprophylaxis and insulin sensitizers require further RCT evaluation.
  • The role of the innate immune system in pregnancy warrants further investigation.